AI-generated summary
This review discusses insomnia and other sleep disturbances in patients with neurodegenerative disorders such as Parkinson's and Alzheimer's disease. The authors report that insomnia can arise from the disease itself or from related factors like pain, depression, or medications, and that management should be individualized, starting with non-pharmacological approaches. They state that bright light therapy may be an effective option for disturbed sleep-wake patterns.
- Who or what was studied
- Patients with neurodegenerative or neurological disorders, such as Parkinson's or Alzheimer's disease, who have comorbid insomnia or sleep disturbances
- Limits stated in the abstract
- The abstract does not report a systematic methodology, study count, or evidence strength, and the bright light therapy claim is described as possibly effective.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Insomnia, Depression, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.